Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

New independent platform to advise investors: Researchpool

Written by DS on in the category news with the tags .


Two former employees of Euronext have established a platform for the dissemination of research. A part of the reports is for free.

Right now, Researchpool has one Belgian writer: the independent analyst Gert De Mesure. You can download his reports on Leasinvest RE, EVS, Barco and Home Invest Belgium, for about 25 euros each.

"If a company pays me for a report, I give it away for free, but of course, I need to be compensated in one way or the other." A portion of the compensation flows to Researchpool.

The Mesure benefits from his work for the Flemish Federation of Investors to write these reports. "I will wait and see if this works out. If my reports are successful, I will write more of them,” concludes De Mesure.

Since early this year, the Portuguese Pedro Fernandes and Briton James Woodley, two Euronext veterans, have been working on an online platform for the distribution of independent research. This week, the Researchpool website went live.

Investors can browse through 2,300 reports of 800 companies in 42 markets. 22 independent research organizations deliver content. Independent houses can make money in two ways. Either they are paid by the companies - which might raise questions about the independence – or by investors.

In the first category, the British Edison is one of the largest players with over 70 analysts and offices in London, New York, Frankfurt, Sydney and Wellington. On the website of Researchpool you can download a report on Argen-X, written by three analysts from Edison with a medical degree. You will also find a very detailed report on Celyad of 16 pages. These reports can be downloaded for free.

Another big player, the French Alpha Value, works on the principle that the investor pays. On Researchpool you can read a report of 47 pages about Bayer for no less than 3737 euros. Though, the offer of Alpha Value on Researchpool is only a fraction of what you find on the website of Alpha Value itself. For Alpha Value it is more interesting that investors buy through their own website to avoid a commission to Research Pool.

Researchpool focuses both on professional and private investors. However it is questionable if small investors are willing to pay for that research.

Read more about: .

RELATED ARTICLES
Costs for treatment of HIV

The University of Hasselt and the AIDS Reference Centre of Ghent University Hospital calculated that the treatment for people infected with HIV in…


Galapagos thinks big

Galapagos, the Mechelen biotech company, quit its inflammation alliance with Janssen under mutual agreement. Galapagos regained the proprietary ri…


Mithra to become the new Omega Pharma?

Businessman Marc Coucke has invested 40 million euros in the Liège pharmaceutical company Mithra. Coucke is now the second largest shareholder, be…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

KU Leuven Biowin GSK Itera Life Science V-Bio Ventures Janssen XpandInnovation UGent Flanders.bio Turnstone

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.